2852 results
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Chagas Disease ( ... Acute Chagas Disease ... • Treatment: ... cruzi + clinical evidence ... without clinical evidence
Driving Impairment in Cirrhosis and Hepatic Encephalopathy 
 - Advise patients not to drive ~3 months
episode - No evidence ... or optimize HE treatment ... medications - Optimize treatment ... of comorbid diseases
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
Splenomegaly Treatment ... • Treatment is ... • Treatment algorithms ... patients with evidence ... von Willebrand disease
Probiotics Guidelines
Adults with C difficile infection
 • Recommendation: Only in the context of a clinical trial
clinical trial • Evidence ... on antibiotic treatment ... Conditional • Evidence ... Children with Crohn's disease ... Conditional • Evidence
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Chagas Disease ( ... Acute Chagas Disease ... • Treatment: ... cruzi + clinical evidence ... without clinical evidence
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
diagnosis #management #treatment ... References: What evidence-based ... mhaus-recommendations/what-evidence-based-interventions-are-recommended-to-alleviate-hyperthermia-associated-with-malignant-hyperthermia ... Diagnosis and treatment ... Journal of Rare Diseases
Tularemia - Diagnosis and Management Summary
Francisella tularensis - Aerobic fastidious gram-negative Coccobacillus - Zoonotic Infection
 •
among children; No evident ... Culture & GS, PCR Treatment ... : • Severe Disease ... Streptomycin • Moderate Disease ... diagnosis #management #treatment
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
and biological evidences ... • Autoimmune diseases ... Adult-onset Still disease ... Unknown cause Treatment ... diagnosis #management #treatment
Chronic Kidney Disease (CKD):

Individualize BP-lowering therapy and treatment targets in people with frailty, high risk of
Chronic Kidney Disease ... BP-lowering therapy and treatment ... Treatments that ... with a strong evidence ... unstable heart disease
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
highly inflammatory disease ... Adult-onset Still disease ... of underlying disease ... Histopathologic criteria: Evidence ... Treatment: • Corticosteroids